Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ischemic Heart Disease

  Free Subscription


Articles published in Cardiovasc Res

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    August 2019
  1. SULTAN CS, Weitnauer M, Turinsky M, Kessler T, et al
    Functional association of a CD40 gene single nucleotide polymorphism with the pathogenesis of coronary heart disease.
    Cardiovasc Res. 2019 Aug 2. pii: 5542951. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2019
  2. ALABAS OA, Jernberg T, Pujades-Rodriguez M, Rutherford MJ, et al
    Statistics on mortality following acute myocardial infarction in 842,897 Europeans.
    Cardiovasc Res. 2019 Jul 26. pii: 5539698. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. SCHWACH V, Fernandes MG, Maas S, Gerhardt S, et al
    Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction.
    Cardiovasc Res. 2019 Jul 9. pii: 5530198. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2019
  4. YANG CF, Chen YY, Singh JP, Hsu SF, et al
    Targeting Protein Tyrosine Phosphatase PTP-PEST for Therapeutic Intervention in Acute Myocardial Infarction.
    Cardiovasc Res. 2019 Jun 22. pii: 5522027. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. HOYER FF, Nahrendorf M
    Interferon- regulates cardiac myeloid cells in myocardial infarction.
    Cardiovasc Res. 2019 Jun 4. pii: 5510546. doi: 10.1093.
    PubMed     Text format    


    May 2019
  6. HUANG P, Wang L, Li Q, Tian X, et al
    Atorvastatin Enhances the Therapeutic Efficacy of Mesenchymal Stem Cells Derived Exosomes in Acute Myocardial Infarction via Up-regulating Long Non-coding RNA H19.
    Cardiovasc Res. 2019 May 22. pii: 5497485. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. SCARSINI R, Banning AP
    DEFINE-ing the next steps in interventional cardiology: updates on coronary physiology, acute myocardial infarction, and dual-antiplatelet therapy from American College of Cardiology 2019.
    Cardiovasc Res. 2019 May 15. pii: 5489797. doi: 10.1093.
    PubMed     Text format    


    April 2019
  8. FINGER S, Knorr M, Molitor M, Schuler R, et al
    A sequential interferon gamma directed chemotactic cellular immune response determines survival and cardiac function post myocardial infarction.
    Cardiovasc Res. 2019 Apr 5. pii: 5428148. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2019
  9. GAST M, Rauch B, Haghikia A, Nakagawa S, et al
    Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patients.
    Cardiovasc Res. 2019 Mar 29. pii: 5423185. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. DE KLEIJN DPV, Chong SY, Wang X, Yatim SMJM, et al
    Toll-like Receptor 7 Deficiency Promotes Survival and Reduces Adverse Left Ventricular Remodeling After Myocardial Infarction.
    Cardiovasc Res. 2019 Mar 4. pii: 5369232. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2019
  11. ZABCZYK M, Natorska J, Zalewski J, Undas A, et al
    Fibrin biofilm can be detected on intracoronary thrombi aspirated from patients with acute myocardial infarction.
    Cardiovasc Res. 2019 Jan 28. pii: 5303509. doi: 10.1093.
    PubMed     Text format    


  12. MADONNA R, Van Laake LW, Botker HE, Davidson SM, et al
    ESC Working Group on Cellular Biology of the Heart: Tissue Engineering and Cell-Based Therapies for Cardiac Repair in Ischemic Heart Disease and Heart Failure.
    Cardiovasc Res. 2019 Jan 17. pii: 5292411. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2018
  13. MATSUMOTO K, Obana M, Kobayashi A, Kihara M, et al
    Blockade of NKG2D/NKG2D Ligand Interaction Attenuated Cardiac Remodeling after Myocardial Infarction.
    Cardiovasc Res. 2018 Oct 11. pii: 5126925. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. KOENEN RR
    No hearty reception; infusion of CXCL4 impedes tissue repair by macrophages after myocardial infarction.
    Cardiovasc Res. 2018 Oct 5. pii: 5115993. doi: 10.1093.
    PubMed     Text format    


  15. KIMURA T, Tajiri K, Sato A, Sakai S, et al
    Tenascin-C Accelerates Adverse Ventricular Remodeling after Myocardial Infarction by Modulating Macrophage Polarization.
    Cardiovasc Res. 2018 Oct 5. pii: 5122727. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2018
  16. SCHLOSS MJ, Horckmans M, Guillamat-Prats R, Hering D, et al
    2-arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction.
    Cardiovasc Res. 2018 Sep 28. pii: 5115994. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2018
  17. LINDSEY ML, Jung M, Yabluchanskiy A, Cannon PL, et al
    Exogenous CXCL4 Infusion Inhibits Macrophage Phagocytosis by Limiting CD36 Signaling to Enhance Post-myocardial Infarction Cardiac Dilation and Mortality.
    Cardiovasc Res. 2018 Aug 29. pii: 5086353. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. VILAHUR G, Gutierrez M, Casani L, Lambert C, et al
    P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs.
    Cardiovasc Res. 2018 Aug 14. pii: 5074301. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. BUENO-BETI C, Novella S, Soleti R, Mompeon A, et al
    Microparticles Harboring Sonic Hedgehog Morphogen Improve the Vasculogenesis Capacity of Endothelial Progenitor Cells Derived from Myocardial Infarction Patients.
    Cardiovasc Res. 2018 Aug 14. pii: 5074321. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. ZHAO M, Fan C, Ernst PJ, Tang Y, et al
    Y-27632 Preconditioning Enhances Transplantation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Myocardial Infarction Mice.
    Cardiovasc Res. 2018 Aug 13. pii: 5073049. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. TOKUTOME M, Matoba T, Nakano Y, Okahara A, et al
    PPARgamma-targeting Nanomedicine Promotes Cardiac Healing After Acute Myocardial Infarction by Skewing Monocyte/Macrophage Polarization in Preclinical Animal Models.
    Cardiovasc Res. 2018 Aug 3. pii: 5066356. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  22. PANAHI M, Papanikolaou A, Torabi A, Zhang JG, et al
    Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition.
    Cardiovasc Res. 2018 Jul 14. pii: 5054000. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. WANG Y, Liu J, Kong Q, Cheng H, et al
    Cardiomyocyte-Specific Deficiency of HSPB1 Worsens Cardiac Dysfunction by Activating NFkappaB-Mediated Leukocyte Recruitment After Myocardial Infarction.
    Cardiovasc Res. 2018 Jul 2. pii: 5047821. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  24. LINDSEY ML
    Reg-ulating macrophage infiltration to alter wound healing following myocardial infarction.
    Cardiovasc Res. 2018 Jun 15. pii: 5038408. doi: 10.1093.
    PubMed     Text format    


    May 2018
  25. LORCHNER H, Hou Y, Adrian-Segarra JM, Kulhei J, et al
    Reg proteins direct accumulation of functionally distinct macrophage subsets after myocardial infarction.
    Cardiovasc Res. 2018 May 30. pii: 5025270. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  26. DEUTSCH MA, Doppler SA, Li X, Lahm H, et al
    Reactivation of the Nkx2.5 cardiac enhancer after myocardial infarction does not presage myogenesis.
    Cardiovasc Res. 2018 Mar 20. pii: 4944453. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. CHEN CW, Wang LL, Zaman S, Gordon J, et al
    Sustained Release of Endothelial Progenitor Cell-Derived Extracellular Vesicles from Shear-Thinning Hydrogels Improves Angiogenesis and Promotes Function after Myocardial Infarction.
    Cardiovasc Res. 2018 Mar 16. pii: 4939452. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2017
  28. ZIEGLER KA, Ahles A, Wille T, Kerler J, et al
    Local sympathetic denervation attenuates myocardial inflammation and improves cardiac function after myocardial infarction in mice.
    Cardiovasc Res. 2017 Nov 24. pii: 4657089. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  29. PARK KC, Gaze DC, Collinson PO, Marber MS, et al
    Cardiac troponins: from myocardial infarction to chronic disease.
    Cardiovasc Res. 2017 Sep 14. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2017
  30. BAYOUMI AS, Teoh JP, Aonuma T, Yuan Z, et al
    MicroRNA-532 protects the heart in acute myocardial infarction, and represses prss23, a positive regulator of endothelial-to-mesenchymal transition.
    Cardiovasc Res. 2017 Jul 11. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2017
  31. SCHOBESBERGER S, Wright P, Tokar S, Bhargava A, et al
    T-tubule remodelling disturbs localized beta2-adrenergic signalling in rat ventricular myocytes during the progression of heart failure.
    Cardiovasc Res. 2017;113:770-782.
    PubMed     Text format     Abstract available


  32. PERRINO C, Barabasi AL, Condorelli G, Davidson SM, et al
    Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.
    Cardiovasc Res. 2017;113:725-736.
    PubMed     Text format     Abstract available


  33. MANSOR LS, Sousa Fialho MDL, Yea G, Coumans WA, et al
    Inhibition of sarcolemmal FAT/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia/reoxygenation.
    Cardiovasc Res. 2017;113:737-748.
    PubMed     Text format     Abstract available


    May 2017
  34. HAUSENLOY DJ, Garcia-Dorado D, Botker HE, Davidson SM, et al
    Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.
    Cardiovasc Res. 2017;113:564-585.
    PubMed     Text format     Abstract available


  35. CHEN Z, Xie J, Hao H, Lin H, et al
    Ablation of periostin inhibits post-infarction myocardial regeneration in neonatal mice mediated by the phosphatidylinositol 3 kinase/glycogen synthase kinase 3beta/cyclin D1 signalling pathway.
    Cardiovasc Res. 2017;113:620-632.
    PubMed     Text format     Abstract available


  36. VINCENT A, Sportouch C, Covinhes A, Barrere C, et al
    Cardiac mGluR1 metabotropic receptors in cardioprotection.
    Cardiovasc Res. 2017;113:644-655.
    PubMed     Text format     Abstract available


  37. VALLE RALEIGH J, Mauro AG, Devarakonda T, Marchetti C, et al
    Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
    Cardiovasc Res. 2017;113:609-619.
    PubMed     Text format     Abstract available


    April 2017
  38. WANG Z, Huang S, Sheng Y, Peng X, et al
    Topiramate modulates post-infarction inflammation primarily by targeting monocytes or macrophages.
    Cardiovasc Res. 2017;113:475-487.
    PubMed     Text format     Abstract available


    March 2017
  39. BROMAGE DI, Pickard JM, Rossello X, Ziff OJ, et al
    Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysis.
    Cardiovasc Res. 2017;113:288-297.
    PubMed     Text format     Abstract available


    February 2017
  40. LIM S, Lee GY, Park HS, Lee DH, et al
    Attenuation of carotid neointimal formation after direct delivery of a recombinant adenovirus expressing glucagon-like peptide-1 in diabetic rats.
    Cardiovasc Res. 2017;113:183-194.
    PubMed     Text format     Abstract available


    January 2017
  41. JOSE ALBURQUERQUE-BEJAR J, Barba I, Valls-Lacalle L, Ruiz-Meana M, et al
    Remote ischemic conditioning provides humoural cross-species cardioprotection through glycine receptor activation.
    Cardiovasc Res. 2017;113:52-60.
    PubMed     Text format     Abstract available


  42. RAWAL S, Munasinghe PE, Shindikar A, Paulin J, et al
    Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy.
    Cardiovasc Res. 2017;113:90-101.
    PubMed     Text format     Abstract available


    November 2016
  43. LI L, Li J, Drum BM, Chen Y, et al
    Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


    July 2016
  44. TAKADA S, Masaki Y, Kinugawa S, Matsumoto J, et al
    Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of GLP-1 receptor signaling.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: